Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature medicine 2020-05, Vol.26 (5), p.803-803
Hauptverfasser: Brudno, Jennifer N., Lam, Norris, Vanasse, Danielle, Shen, Yueh-wei, Rose, Jeremy J., Rossi, John, Xue, Allen, Bot, Adrian, Scholler, Nathalie, Mikkilineni, Lekha, Roschewski, Mark, Dean, Robert, Cachau, Raul, Youkharibache, Philippe, Patel, Rashmika, Hansen, Brenna, Stroncek, David F., Rosenberg, Steven A., Gress, Ronald E., Kochenderfer, James N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 803
container_issue 5
container_start_page 803
container_title Nature medicine
container_volume 26
creator Brudno, Jennifer N.
Lam, Norris
Vanasse, Danielle
Shen, Yueh-wei
Rose, Jeremy J.
Rossi, John
Xue, Allen
Bot, Adrian
Scholler, Nathalie
Mikkilineni, Lekha
Roschewski, Mark
Dean, Robert
Cachau, Raul
Youkharibache, Philippe
Patel, Rashmika
Hansen, Brenna
Stroncek, David F.
Rosenberg, Steven A.
Gress, Ronald E.
Kochenderfer, James N.
description An amendment to this paper has been published and can be accessed via a link at the top of the paper.
doi_str_mv 10.1038/s41591-020-0864-x
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7819238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A623825926</galeid><sourcerecordid>A623825926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471x-c72edd16c3333257ab6feee518fab14471035528f69e27ae2e02dcb59be1bd813</originalsourceid><addsrcrecordid>eNqNkltrFDEYhgdRbK3-AG8kIIhepCaZyRy8ENb1VCgU2irehczMl5mUmWRNMrp77w83w65tVyqYXOT0vG8SvjdJnlJyTElavvYZ5RXFhBFMyjzD63vJIeVZjmlBvt2Pc1KUuKx4fpA88v6KEJISXj1MDlLGKprR_DD5tZhCbx1aWuegCdqaN-hCKggbJE2LFEivaz3ouLYqbgWNl-9phZaLc3SJGhgGj37q0CM1DcMG9dMoDaq1abXpUGtHqY1H2qCVDBpM2MHv8KxEw2Zc9ZF5nDxQcvDwZDceJV8-frhcfsanZ59OlotT3GQFXeOmYNC2NG_S2BgvZJ0rAOC0VLKmWWRIyjkrVV4BKyQwIKxtal7VQOu2pOlR8nbru5rqEdomPsjJQaycHqXbCCu12D8xuhed_SGKklYsLaPBy52Bs98n8EGM2s9fkQbs5AVLK0JzkmXzXc__Qq_s5Ez8nmAZiWY5r4obqpMDCG2Ujfc2s6lY5BFivGJ5pPAdVAcG4iOtAaXj9h5_fAcfewujbu4UvNoTRCbAOnRy8l6cXJz_P3v2dZ99cYvtQQ6h93aY5pz5fZBuwcZZ7x2o66JQIuasi23WRcy6mLMu1lHz7HY1rxV_wh0BtgV8PDIduJsS_Nv1NwpZBwM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2402386597</pqid></control><display><type>article</type><title>Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma</title><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Brudno, Jennifer N. ; Lam, Norris ; Vanasse, Danielle ; Shen, Yueh-wei ; Rose, Jeremy J. ; Rossi, John ; Xue, Allen ; Bot, Adrian ; Scholler, Nathalie ; Mikkilineni, Lekha ; Roschewski, Mark ; Dean, Robert ; Cachau, Raul ; Youkharibache, Philippe ; Patel, Rashmika ; Hansen, Brenna ; Stroncek, David F. ; Rosenberg, Steven A. ; Gress, Ronald E. ; Kochenderfer, James N.</creator><creatorcontrib>Brudno, Jennifer N. ; Lam, Norris ; Vanasse, Danielle ; Shen, Yueh-wei ; Rose, Jeremy J. ; Rossi, John ; Xue, Allen ; Bot, Adrian ; Scholler, Nathalie ; Mikkilineni, Lekha ; Roschewski, Mark ; Dean, Robert ; Cachau, Raul ; Youkharibache, Philippe ; Patel, Rashmika ; Hansen, Brenna ; Stroncek, David F. ; Rosenberg, Steven A. ; Gress, Ronald E. ; Kochenderfer, James N.</creatorcontrib><description>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</description><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/s41591-020-0864-x</identifier><identifier>PMID: 32291416</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/250 ; 631/250/251 ; 692/308 ; 692/308/2779/109/1940 ; 692/308/575 ; 692/699/67/1059/2325 ; 692/699/67/1990/291 ; Author Correction ; B-cell lymphoma ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Care and treatment ; CD19 antigen ; Infectious Diseases ; Lymphocytes ; Lymphocytes B ; Lymphocytes T ; Lymphoma ; Lymphomas ; Metabolic Diseases ; Molecular Medicine ; Neurosciences ; T cells</subject><ispartof>Nature medicine, 2020-05, Vol.26 (5), p.803-803</ispartof><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2020</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-3743-7102 ; 0000-0001-9260-2102 ; 0000-0002-4362-9875</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41591-020-0864-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41591-020-0864-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32291416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brudno, Jennifer N.</creatorcontrib><creatorcontrib>Lam, Norris</creatorcontrib><creatorcontrib>Vanasse, Danielle</creatorcontrib><creatorcontrib>Shen, Yueh-wei</creatorcontrib><creatorcontrib>Rose, Jeremy J.</creatorcontrib><creatorcontrib>Rossi, John</creatorcontrib><creatorcontrib>Xue, Allen</creatorcontrib><creatorcontrib>Bot, Adrian</creatorcontrib><creatorcontrib>Scholler, Nathalie</creatorcontrib><creatorcontrib>Mikkilineni, Lekha</creatorcontrib><creatorcontrib>Roschewski, Mark</creatorcontrib><creatorcontrib>Dean, Robert</creatorcontrib><creatorcontrib>Cachau, Raul</creatorcontrib><creatorcontrib>Youkharibache, Philippe</creatorcontrib><creatorcontrib>Patel, Rashmika</creatorcontrib><creatorcontrib>Hansen, Brenna</creatorcontrib><creatorcontrib>Stroncek, David F.</creatorcontrib><creatorcontrib>Rosenberg, Steven A.</creatorcontrib><creatorcontrib>Gress, Ronald E.</creatorcontrib><creatorcontrib>Kochenderfer, James N.</creatorcontrib><title>Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><description>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</description><subject>631/250</subject><subject>631/250/251</subject><subject>692/308</subject><subject>692/308/2779/109/1940</subject><subject>692/308/575</subject><subject>692/699/67/1059/2325</subject><subject>692/699/67/1990/291</subject><subject>Author Correction</subject><subject>B-cell lymphoma</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>CD19 antigen</subject><subject>Infectious Diseases</subject><subject>Lymphocytes</subject><subject>Lymphocytes B</subject><subject>Lymphocytes T</subject><subject>Lymphoma</subject><subject>Lymphomas</subject><subject>Metabolic Diseases</subject><subject>Molecular Medicine</subject><subject>Neurosciences</subject><subject>T cells</subject><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkltrFDEYhgdRbK3-AG8kIIhepCaZyRy8ENb1VCgU2irehczMl5mUmWRNMrp77w83w65tVyqYXOT0vG8SvjdJnlJyTElavvYZ5RXFhBFMyjzD63vJIeVZjmlBvt2Pc1KUuKx4fpA88v6KEJISXj1MDlLGKprR_DD5tZhCbx1aWuegCdqaN-hCKggbJE2LFEivaz3ouLYqbgWNl-9phZaLc3SJGhgGj37q0CM1DcMG9dMoDaq1abXpUGtHqY1H2qCVDBpM2MHv8KxEw2Zc9ZF5nDxQcvDwZDceJV8-frhcfsanZ59OlotT3GQFXeOmYNC2NG_S2BgvZJ0rAOC0VLKmWWRIyjkrVV4BKyQwIKxtal7VQOu2pOlR8nbru5rqEdomPsjJQaycHqXbCCu12D8xuhed_SGKklYsLaPBy52Bs98n8EGM2s9fkQbs5AVLK0JzkmXzXc__Qq_s5Ez8nmAZiWY5r4obqpMDCG2Ujfc2s6lY5BFivGJ5pPAdVAcG4iOtAaXj9h5_fAcfewujbu4UvNoTRCbAOnRy8l6cXJz_P3v2dZ99cYvtQQ6h93aY5pz5fZBuwcZZ7x2o66JQIuasi23WRcy6mLMu1lHz7HY1rxV_wh0BtgV8PDIduJsS_Nv1NwpZBwM</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Brudno, Jennifer N.</creator><creator>Lam, Norris</creator><creator>Vanasse, Danielle</creator><creator>Shen, Yueh-wei</creator><creator>Rose, Jeremy J.</creator><creator>Rossi, John</creator><creator>Xue, Allen</creator><creator>Bot, Adrian</creator><creator>Scholler, Nathalie</creator><creator>Mikkilineni, Lekha</creator><creator>Roschewski, Mark</creator><creator>Dean, Robert</creator><creator>Cachau, Raul</creator><creator>Youkharibache, Philippe</creator><creator>Patel, Rashmika</creator><creator>Hansen, Brenna</creator><creator>Stroncek, David F.</creator><creator>Rosenberg, Steven A.</creator><creator>Gress, Ronald E.</creator><creator>Kochenderfer, James N.</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3743-7102</orcidid><orcidid>https://orcid.org/0000-0001-9260-2102</orcidid><orcidid>https://orcid.org/0000-0002-4362-9875</orcidid></search><sort><creationdate>20200501</creationdate><title>Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma</title><author>Brudno, Jennifer N. ; Lam, Norris ; Vanasse, Danielle ; Shen, Yueh-wei ; Rose, Jeremy J. ; Rossi, John ; Xue, Allen ; Bot, Adrian ; Scholler, Nathalie ; Mikkilineni, Lekha ; Roschewski, Mark ; Dean, Robert ; Cachau, Raul ; Youkharibache, Philippe ; Patel, Rashmika ; Hansen, Brenna ; Stroncek, David F. ; Rosenberg, Steven A. ; Gress, Ronald E. ; Kochenderfer, James N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471x-c72edd16c3333257ab6feee518fab14471035528f69e27ae2e02dcb59be1bd813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/250</topic><topic>631/250/251</topic><topic>692/308</topic><topic>692/308/2779/109/1940</topic><topic>692/308/575</topic><topic>692/699/67/1059/2325</topic><topic>692/699/67/1990/291</topic><topic>Author Correction</topic><topic>B-cell lymphoma</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>CD19 antigen</topic><topic>Infectious Diseases</topic><topic>Lymphocytes</topic><topic>Lymphocytes B</topic><topic>Lymphocytes T</topic><topic>Lymphoma</topic><topic>Lymphomas</topic><topic>Metabolic Diseases</topic><topic>Molecular Medicine</topic><topic>Neurosciences</topic><topic>T cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brudno, Jennifer N.</creatorcontrib><creatorcontrib>Lam, Norris</creatorcontrib><creatorcontrib>Vanasse, Danielle</creatorcontrib><creatorcontrib>Shen, Yueh-wei</creatorcontrib><creatorcontrib>Rose, Jeremy J.</creatorcontrib><creatorcontrib>Rossi, John</creatorcontrib><creatorcontrib>Xue, Allen</creatorcontrib><creatorcontrib>Bot, Adrian</creatorcontrib><creatorcontrib>Scholler, Nathalie</creatorcontrib><creatorcontrib>Mikkilineni, Lekha</creatorcontrib><creatorcontrib>Roschewski, Mark</creatorcontrib><creatorcontrib>Dean, Robert</creatorcontrib><creatorcontrib>Cachau, Raul</creatorcontrib><creatorcontrib>Youkharibache, Philippe</creatorcontrib><creatorcontrib>Patel, Rashmika</creatorcontrib><creatorcontrib>Hansen, Brenna</creatorcontrib><creatorcontrib>Stroncek, David F.</creatorcontrib><creatorcontrib>Rosenberg, Steven A.</creatorcontrib><creatorcontrib>Gress, Ronald E.</creatorcontrib><creatorcontrib>Kochenderfer, James N.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brudno, Jennifer N.</au><au>Lam, Norris</au><au>Vanasse, Danielle</au><au>Shen, Yueh-wei</au><au>Rose, Jeremy J.</au><au>Rossi, John</au><au>Xue, Allen</au><au>Bot, Adrian</au><au>Scholler, Nathalie</au><au>Mikkilineni, Lekha</au><au>Roschewski, Mark</au><au>Dean, Robert</au><au>Cachau, Raul</au><au>Youkharibache, Philippe</au><au>Patel, Rashmika</au><au>Hansen, Brenna</au><au>Stroncek, David F.</au><au>Rosenberg, Steven A.</au><au>Gress, Ronald E.</au><au>Kochenderfer, James N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>26</volume><issue>5</issue><spage>803</spage><epage>803</epage><pages>803-803</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><abstract>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>32291416</pmid><doi>10.1038/s41591-020-0864-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3743-7102</orcidid><orcidid>https://orcid.org/0000-0001-9260-2102</orcidid><orcidid>https://orcid.org/0000-0002-4362-9875</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-8956
ispartof Nature medicine, 2020-05, Vol.26 (5), p.803-803
issn 1078-8956
1546-170X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7819238
source Nature Journals Online; SpringerLink Journals - AutoHoldings
subjects 631/250
631/250/251
692/308
692/308/2779/109/1940
692/308/575
692/699/67/1059/2325
692/699/67/1990/291
Author Correction
B-cell lymphoma
Biomedical and Life Sciences
Biomedicine
Cancer Research
Care and treatment
CD19 antigen
Infectious Diseases
Lymphocytes
Lymphocytes B
Lymphocytes T
Lymphoma
Lymphomas
Metabolic Diseases
Molecular Medicine
Neurosciences
T cells
title Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T15%3A41%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Author%20Correction:%20Safety%20and%20feasibility%20of%20anti-CD19%20CAR%20T%20cells%20with%20fully%20human%20binding%20domains%20in%20patients%20with%20B-cell%20lymphoma&rft.jtitle=Nature%20medicine&rft.au=Brudno,%20Jennifer%20N.&rft.date=2020-05-01&rft.volume=26&rft.issue=5&rft.spage=803&rft.epage=803&rft.pages=803-803&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/s41591-020-0864-x&rft_dat=%3Cgale_pubme%3EA623825926%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2402386597&rft_id=info:pmid/32291416&rft_galeid=A623825926&rfr_iscdi=true